Status:
UNKNOWN
Explore Transplant @Home Within Kaiser Permanente Southern California
Lead Sponsor:
The Methodist Hospital Research Institute
Collaborating Sponsors:
Kaiser Permanente
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Today, there are 25 million Americans with chronic kidney disease (CKD) and 660,000 patients in full kidney failure, the final CKD stage, known as end stage renal disease (ESRD). Over half of ESRD pat...
Detailed Description
Today, there are 25 million Americans with chronic kidney disease (CKD) who are at risk for kidney failure and 660,000 patients with end-stage renal disease (ESRD). To sustain life, ESRD patients, amo...
Eligibility Criteria
Inclusion
- Participant must be at least 18 years of age.
- Participant must self-identify as African American, White, Hispanic, or Asian.
- Participant must currently be classified as having CKD 3, 4 or 5.
- Participant must be able to speak and read in English or Spanish.
Exclusion
- Participant is not classified as having CKD 3,4, or 5.
- Participant cannot speak or read in English or Spanish.
Key Trial Info
Start Date :
July 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
977 Patients enrolled
Trial Details
Trial ID
NCT03389932
Start Date
July 11 2018
End Date
December 31 2024
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Research and Evaluation
Pasadena, California, United States, 91101